» Articles » PMID: 6199788

Murine Monoclonal Antibody to a Single Protein Neutralizes the Infectivity of Human Cytomegalovirus

Overview
Specialty Science
Date 1984 Feb 1
PMID 6199788
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Murine monoclonal antibodies to human cytomegalovirus (CMV) strain AD169 were selected that neutralized virus infectivity. One monoclonal antibody-producing hybridoma, 1G6, was used to produce ascites fluid from which immunoglobulin was isolated. This antibody efficiently neutralized CMV AD169, other laboratory strains (Towne, Davis), and clinical isolates of CMV in early tissue culture passage (less than 10) in the absence of complement. The antibody immunoprecipitated a single 86,000-dalton protein from both laboratory and clinical strains. This viral protein was demonstrated by indirect immunofluorescence to be localized in the cytoplasm of CMV-infected cells.

Citing Articles

A derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cells.

Stegmann C, Hochdorfer D, Lieber D, Subramanian N, Stohr D, Laib Sampaio K PLoS Pathog. 2017; 13(4):e1006273.

PMID: 28403220 PMC: 5389858. DOI: 10.1371/journal.ppat.1006273.


Developmental regulation of human cytomegalovirus receptors in cytotrophoblasts correlates with distinct replication sites in the placenta.

Maidji E, Genbacev O, Chang H, Pereira L J Virol. 2007; 81(9):4701-12.

PMID: 17314173 PMC: 1900158. DOI: 10.1128/JVI.02748-06.


Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism.

Wang D, Shenk T Proc Natl Acad Sci U S A. 2005; 102(50):18153-8.

PMID: 16319222 PMC: 1312424. DOI: 10.1073/pnas.0509201102.


Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.

Kinzler E, Compton T J Virol. 2005; 79(12):7827-37.

PMID: 15919936 PMC: 1143629. DOI: 10.1128/JVI.79.12.7827-7837.2005.


The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.

Rasmussen L, Geissler A, Cowan C, Chase A, Winters M J Virol. 2002; 76(21):10841-8.

PMID: 12368327 PMC: 136653. DOI: 10.1128/jvi.76.21.10841-10848.2002.


References
1.
Eisenberg R, Ponce de Leon M, Cohen G . Comparative structural analysis of glycoprotein gD of herpes simplex virus types 1 and 2. J Virol. 1980; 35(2):428-35. PMC: 288828. DOI: 10.1128/JVI.35.2.428-435.1980. View

2.
Thorley-Lawson D, Geilinger K . Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Proc Natl Acad Sci U S A. 1980; 77(9):5307-11. PMC: 350047. DOI: 10.1073/pnas.77.9.5307. View

3.
Rasmussen L, Kelsall D, Nelson R, Carney W, Hirsch M, Winston D . Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. J Infect Dis. 1982; 145(2):191-9. DOI: 10.1093/infdis/145.2.191. View

4.
Eisenberg R, Long D, Pereira L, Hampar B, ZWEIG M, Cohen G . Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1. J Virol. 1982; 41(2):478-88. PMC: 256776. DOI: 10.1128/JVI.41.2.478-488.1982. View

5.
Para M, Baucke R, Spear P . Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors. J Virol. 1982; 41(1):129-36. PMC: 256733. DOI: 10.1128/JVI.41.1.129-136.1982. View